Marker Therapeutics (NASDAQ: MRKR) CEO and President: Peter Hoang
Listen now
Description
  Marker Therapeutics (NASDAQ: MRKR) CEO and President: Peter Hoang  
More Episodes
THIS INTERVIEW HAS EXPIRED
Published 05/02/19
Interview with CEO Adam Burk
Published 02/12/19